PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 186 filers reported holding PDL BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $783,000 | -55.9% | 303,534 | -63.1% | 0.00% | -50.0% |
| Q1 2017 | $1,776,000 | +536.6% | 822,592 | +525.9% | 0.00% | +100.0% |
| Q4 2016 | $279,000 | -43.4% | 131,433 | -10.8% | 0.00% | 0.0% |
| Q3 2016 | $493,000 | -27.0% | 147,281 | -31.5% | 0.00% | 0.0% |
| Q2 2016 | $675,000 | -20.2% | 214,879 | -19.5% | 0.00% | -50.0% |
| Q1 2016 | $846,000 | -98.7% | 266,935 | -96.9% | 0.00% | -98.5% |
| Q4 2014 | $66,959,000 | -99.9% | 8,684,695 | -0.4% | 0.13% | +50.6% |
| Q3 2014 | $65,154,797,000 | -22.9% | 8,722,195 | -0.1% | 0.09% | -17.1% |
| Q2 2014 | $84,498,075,000 | +15.6% | 8,729,140 | -0.8% | 0.10% | +28.0% |
| Q1 2014 | $73,103,402,000 | +69.1% | 8,797,040 | +71.8% | 0.08% | +51.9% |
| Q4 2013 | $43,222,658,000 | +27.0% | 5,121,168 | +20.0% | 0.05% | -34.9% |
| Q3 2013 | $34,020,487,000 | +27.2% | 4,268,568 | +23.2% | 0.08% | +16.9% |
| Q2 2013 | $26,737,201,000 | – | 3,463,368 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |